The Lysophospholipase PNPLA7 Controls Hepatic Choline and Methionine Metabolism
Biomolecules · 2023
DOI: 10.3390/biom13030471 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biomolecules, 2023. Verfasst von Sayaka Harada und 8 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Microenvironmental and Metabolic Health Sciences, Center for Disease Biology and Integrative Medicine, Graduate School of Medicine, The…. Hauptthemen laut MEDLINE: Choline, Lysophospholipase. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 78 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science, Japan Agency for Medical Research and Development.
Abstract (Originalsprache)
The in vivo roles of lysophospholipase, which cleaves a fatty acyl ester of lysophospholipid, remained unclear. Recently, we have unraveled a previously unrecognized physiological role of the lysophospholipase PNPLA7, a member of the Ca2+-independent phospholipase A2 (iPLA2) family, as a key regulator of the production of glycerophosphocholine (GPC), a precursor of endogenous choline, whose methyl groups are preferentially fluxed into the methionine cycle in the liver. PNPLA7 deficiency in mice markedly decreases hepatic GPC, choline, and several metabolites related to choline/methionine metabolism, leading to various symptoms reminiscent of methionine shortage. Overall metabolic alterations in the liver of Pnpla7-null mice in vivo largely recapitulate those in methionine-deprived hepatocytes in vitro. Reduction of the methyl donor S-adenosylmethionine (SAM) after methionine deprivation decreases the methylation of the PNPLA7 gene promoter, relieves PNPLA7 expression, and thereby increases GPC and choline levels, likely as a compensatory adaptation. In line with the view that SAM prevents the development of liver cancer, the expression of PNPLA7, as well as several enzymes in the choline/methionine metabolism, is reduced in human hepatocellular carcinoma. These findings uncover an unexplored role of a lysophospholipase in hepatic phospholipid catabolism coupled with choline/methionine metabolism.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Microenvironmental and Metabolic Health Sciences, Center for Disease Biology and Integrative Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo 113-8655, Japan.
- Department of Radiation Effects Research, National Institutes for Quantum and Radiological Science and Technology, Chiba 263-8555, Japan.
- Laboratory of Biomembrane, Department of Basic Medical Sciences, Tokyo Metropolitan Institute of Medical Science, Tokyo 156-8506, Japan.
- Department of Clinical Laboratory Medicine, The University of Tokyo, Tokyo 113-8655, Japan.
ORCID-Profile: Yoshitaka Taketomi, Tetsuya Hirabayashi, Yutaka Yatomi, Makoto Murakami
Förderung
- Japan Society for the Promotion of Science
- Japan Agency for Medical Research and Development
Zitieren
APA
Harada, S., Taketomi, Y., Aiba, T., Kawaguchi, M., Hirabayashi, T., Uranbileg, B., Kurano, M., Yatomi, Y., & Murakami, M. (2023). The Lysophospholipase PNPLA7 Controls Hepatic Choline and Methionine Metabolism. Biomolecules. https://doi.org/10.3390/biom13030471
Vancouver
Harada S, Taketomi Y, Aiba T, Kawaguchi M, Hirabayashi T, Uranbileg B, et al. The Lysophospholipase PNPLA7 Controls Hepatic Choline and Methionine Metabolism. Biomolecules. 2023. doi:10.3390/biom13030471
BibTeX
@article{Harada2023,
author = {Harada, Sayaka and Taketomi, Yoshitaka and Aiba, Toshiki and Kawaguchi, Mai and Hirabayashi, Tetsuya and Uranbileg, Baasanjav and Kurano, Makoto and Yatomi, Yutaka and Murakami, Makoto},
title = {The Lysophospholipase PNPLA7 Controls Hepatic Choline and Methionine Metabolism},
journal = {Biomolecules},
year = {2023},
doi = {10.3390/biom13030471}
}
EUVIMED